Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Brain Neoplasms 21 Carcinoma, Non-Small-Cell Lung 16 Pancreatic Neoplasms 11 Neoplasm Metastasis 11 Prostatic Neoplasms 9 Melanoma 9 Lung Neoplasms 8 Glioblastoma 8 Breast Neoplasms 8 Carcinoma, Hepatocellular 7 Squamous Cell Carcinoma of Head and Neck 6 Glioma 6 Carcinoma, Renal Cell 6 Neoplasms 5 Colorectal Neoplasms 5 Head and Neck Neoplasms 4 Uveal Melanoma 3 Oligodendroglioma 3 Liver Neoplasms 3 Gliosarcoma 3 Astrocytoma 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2

Interventions

sipuleucel-T 1 apalutamide 1 Radiosurgery 1 Prednisone 1 Docetaxel 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostate Cancer Metastatic × Radiosurgery × Clear all

NCT05567770 2023-08-24

ACTION

Weill Medical College of Cornell University

Phase 1 Withdrawn

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡